A single dose of psilocybin has a lasting therapeutic effect on migraine headache, according to a new placebo-controlled study.
Read morePsychedelics and Color Blindness
A new report published in the journal Drug Science, Policy and Law has found that some people who used psychedelics recreationally were able to see and discern colors they hadn’t been able to before. Even more surprising, some said they experienced these vision improvements long after taking psychedelics.
Read morePsychedelics in Groups
First study of its kind shows potential of taking psychedelics in a group setting.
Read moreMore on the Psychedelic Revolution
From the NYTimes: The psychedelic revolution Is coming, and psychiatry may never be the same.
Psilocybin and MDMA are poised to be the hottest new therapeutics since Prozac. Universities want in, and so does Wall Street. Some worry a push to loosen access could bring unintended consequences.
Read morePsychedelic Timeline
Here’s a timeline through psychedelic events in human history, from over 7000 years ago.
Read moreLearning About Psychedelics from Animals
As we imagine a future with positive cultural norms around psychedelics, the book “Animals and Psychedelics: The Natural World and the Instinct to Alter Consciousness” by Italian ethnobotanist and ethnomycologist Giorgio Samorini may offer us some guidance.
Read moreBrain Trauma and Psychedelics
A growing list of athletes are looking to psychedelic substances for healing brain trauma.
Read morePsychedelics Without Tripping
Psychedelic drugs without the trip?
This sensor could help seek them out. An easier way to identify non-hallucinogenic psychedelics could aid treatment for illnesses such as depression and PTSD.
Read moreThe ‘Godfather of MDMA'
The California chemist Sasha Shulgin is known as the ‘Godfather of MDMA,’ but his legacy lies in countless drugs that remain a mystery to scientists and psychonauts alike. Keep reading to learn more.
Read moreMushrooms and Healing
Ezra Klein of the New York Times considers the healing potential of psilocybin mushrooms in an op-ed that covers the success of Oregon's Measure 109, which creates a "support infrastructure through which psychedelic mushrooms can be woven into everyday life."
Klein shares the "cautious" yet supportive perspective of MAPS Founder and Executive Director Rick Doblin, Ph.D., on the initiative: "I worry those with the most at stake in terms of licenses will be fearful of participating, when those are the people we most want to participate."
Read moreRethinking Psychedelics
Here’s another look at the psychedelic renaissance underway.
Read more